Ikegami Y - Search Results

1

Transport mechanism-based drug molecular design: novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells.

Ishikawa T, Ikegami Y, Sano K, Nakagawa H, Sawada S. Ishikawa T, et al. Among authors: ikegami y. Curr Pharm Des. 2006;12(3):313-25. doi: 10.2174/138161206775201992. Curr Pharm Des. 2006. PMID: 16454746 Review.

2

Novel camptothecin analogues that circumvent ABCG2-associated drug resistance in human tumor cells.

Yoshikawa M, Ikegami Y, Hayasaka S, Ishii K, Ito A, Sano K, Suzuki T, Togawa T, Yoshida H, Soda H, Oka M, Kohno S, Sawada S, Ishikawa T, Tanabe S. Yoshikawa M, et al. Among authors: ikegami y. Int J Cancer. 2004 Jul 20;110(6):921-7. doi: 10.1002/ijc.20216. Int J Cancer. 2004. PMID: 15170677 Free article.

3

Transport of SN-38 by the wild type of human ABC transporter ABCG2 and its inhibition by quercetin, a natural flavonoid.

Yoshikawa M, Ikegami Y, Sano K, Yoshida H, Mitomo H, Sawada S, Ishikawa T. Yoshikawa M, et al. Among authors: ikegami y. J Exp Ther Oncol. 2004 Apr;4(1):25-35. J Exp Ther Oncol. 2004. PMID: 15255290

4

Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer.

Nakagawa H, Saito H, Ikegami Y, Aida-Hyugaji S, Sawada S, Ishikawa T. Nakagawa H, et al. Among authors: ikegami y. Cancer Lett. 2006 Mar 8;234(1):81-9. doi: 10.1016/j.canlet.2005.05.052. Epub 2005 Nov 23. Cancer Lett. 2006. PMID: 16309825 Review.

5

Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2.

Tamura A, Wakabayashi K, Onishi Y, Takeda M, Ikegami Y, Sawada S, Tsuji M, Matsuda Y, Ishikawa T. Tamura A, et al. Among authors: ikegami y. Cancer Sci. 2007 Feb;98(2):231-9. doi: 10.1111/j.1349-7006.2006.00371.x. Cancer Sci. 2007. PMID: 17297656 Free article.

6

Human ABC transporter ABCG2 in cancer chemotherapy: drug molecular design to circumvent multidrug resistance.

Ishikawa T, Saito H, Hirano H, Inoue Y, Ikegami Y. Ishikawa T, et al. Among authors: ikegami y. Methods Mol Biol. 2012;910:267-78. doi: 10.1007/978-1-61779-965-5_11. Methods Mol Biol. 2012. PMID: 22821599

7

Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.

Ishikawa T, Kajimoto Y, Sun W, Nakagawa H, Inoue Y, Ikegami Y, Miyatake S, Kuroiwa T. Ishikawa T, et al. Among authors: ikegami y. J Pharm Sci. 2013 Sep;102(9):3058-69. doi: 10.1002/jps.23563. Epub 2013 May 6. J Pharm Sci. 2013. PMID: 23650051 Review.

8

Gefitinib enhances the antitumor activity of CPT-11 in vitro and in vivo by inhibiting ABCG2 but not ABCB1: a new clue to circumvent gastrointestinal toxicity risk.

Inoue Y, Ikegami Y, Sano K, Suzuki T, Yoshida H, Nakamura Y, Nakagawa H, Ishikawa T. Inoue Y, et al. Among authors: ikegami y. Chemotherapy. 2013;59(4):260-72. doi: 10.1159/000357772. Epub 2014 Jan 17. Chemotherapy. 2013. PMID: 24457609

9

Simple non-ion-paired high-performance liquid chromatographic method for simultaneous quantitation of carboxylate and lactone forms of 14 new camptothecin derivatives.

Sano K, Yoshikawa M, Hayasaka S, Satake K, Ikegami Y, Yoshida H, Ishikawa T, Sawada S, Tanabe S. Sano K, et al. Among authors: ikegami y. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Sep 25;795(1):25-34. doi: 10.1016/s1570-0232(03)00485-9. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12957166

10

[Drug resistance mediated by ABC transporters].

Yoshikawa M, Ito A, Ishikawa T, Ikegami Y. Yoshikawa M, et al. Among authors: ikegami y. Gan To Kagaku Ryoho. 2004 Jan;31(1):1-6. Gan To Kagaku Ryoho. 2004. PMID: 14750312 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

591 results

Search Page